Drugs / Sabin-Based Inactivated Poliomyelitis Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03092791 | Jun 2017 → Apr 2018 | poliomyelitis | Takeda | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin-Based Inactivated Poliomyelitis Vaccine | “Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)” NCT03092791 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03092791 ↗ |
| Modality | Vaccine | “The vaccine being tested in this study is called sIPV.” NCT03092791 ↗ |
| Route | Intramuscular | “sIPV intramuscular injection” NCT03092791 ↗ |